Marca Nominativa depositada no INPI em 25/08/2023 por Ultragenyx Pharmaceutical Inc., processo nº 501752851, nas classes 05, 42, 44. Registro em vigor até 25/08/2033.
| Número do processo | 501752851 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 25/08/2023 |
| Data da concessão | 25/03/2025 |
| Vigência até | 25/08/2033 |
| Titular | Ultragenyx Pharmaceutical Inc. |
| UF · País | — · US |
Pharmaceutical preparations and substances for the treatment of metabolic and rare diseases and disorders; gene therapy products for the treatment of metabolic and rare diseases and disorders.;
Research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of gene therapy, metabolic, and rare diseases and disorders; biomedical research in the field of gene therapy design and delivery; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for others in the field of gene therapy design and delivery; compiling and sharing of patient data for research purposes in the field of metabolic and rare diseases and disorders; medical and scientific research information in the field of metabolic and rare diseases and disorders.;
Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of metabolic and rare diseases and disorders.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501752851 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas3 despacho(s) publicado(s) na Revista da Propriedade Industrial.